Immunocore Holdings (IMCR) Other Accumulated Expenses (2022 - 2024)

Immunocore Holdings has disclosed Other Accumulated Expenses across 3 years of filings, most recently posting $7.5 million for Q1 2024.

• Other Accumulated Expenses for Q1 2024 came in at $7.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $7.5 million (changed N/A YoY), and the FY2023 annual result was $6.0 million, up 62.74% from the prior year.
• Other Accumulated Expenses came in at $7.5 million for Q1 2024 at Immunocore Holdings, up from $6.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $7.5 million in Q1 2024 to a low of $3.7 million in Q4 2022.
• The 3-year median for Other Accumulated Expenses is $6.0 million (2023), against an average of $5.7 million.
• Peak annual rise in Other Accumulated Expenses reached 62.74% in 2023, while the deepest fall reached 62.74% in 2023.
• Immunocore Holdings' Other Accumulated Expenses stood at $3.7 million in 2022, then soared by 62.74% to $6.0 million in 2023, then rose by 24.49% to $7.5 million in 2024.
• The last three Other Accumulated Expenses figures came in at $7.5 million (Q1 2024), $6.0 million (Q4 2023), and $3.7 million (Q4 2022), per Business Quant data.